Pfizer › Compliance

News & Analysis as of May 22, 2013

Lawsuits Claim SSRIs Can Cause Severe Birth Defects

Spring 2013 Eye on China Newsletter

by Mark Aiello, Andrew S. Baluch, Stephen Bent, James Ewing, Richard Florsheim, Robert Iseman, Robert Lee, Zhu Julie Lee, Song Lin, Chao Meng, Steven Rizzi, Selig Sacks, David W. Simon | Foley & Lardner LLP on 4/30/2013

Legal News: Eye on China Quarterly Newsletter offers companies helpful insight as they successfully navigate China’s complex and ever-changing legal and regulatory environment. In this issue, we focus on the following...more

Pfizer FCPA Settlement Emphasizes the Importance of Robust Compliance Programs for the Healthcare Industry

by Bora Rawcliffe | Sheppard Mullin Richter & Hampton LLP on 1/23/2013

The healthcare industry has been under increased SEC and DOJ scrutiny lately for potential FCPA violations. What has been described as an “industry sweep,” has focused primarily on medical device and pharmaceutical companies....more

2 Results

| Page: of 1 | WORKING...

View per page

Home

Legal News

Find a Lawyer

Browse Subjects

Subscribe

Pro Services

For Reporters

Pfizer › Compliance

Spring 2013 Eye on China Newsletter

Pfizer FCPA Settlement Emphasizes the Importance of Robust Compliance Programs for the Healthcare Industry

Expand Your Reach